+ All Categories
Home > Health & Medicine > Using risk-based approaches across the product lifecycle to simplify, standardise & enhance the...

Using risk-based approaches across the product lifecycle to simplify, standardise & enhance the...

Date post: 12-Apr-2017
Category:
Upload: mymedsme
View: 241 times
Download: 1 times
Share this document with a friend
28
Transcript

0%

20%

40%

60%

80%

100%

Manufacturersubmitted -Expedited

reports

Manufacturersubmitted -

Periodicreports

Direct reportsby HCPs &

Patients

Incompletereports

Completereports

2% 3% 1%

11%

15%

5%

32%

4% 6%

5%

9%

12%

12%

In pregnancy

In this age group

In women

Because of new non-clinical data raises

safety concerns

Because the class of meds has just come under scrutiny

due to a competitor safety issue

Related to the abuse of this medicine

In real world use

In this ethnic group

In a new disease area

Because the product has just gone OTC

.

S

• ‘Informative Reports have

greatest impact’


Recommended